Lagging Its Neighbours, France Tries To Speed Up COVID-19 Vaccinations
PARIS: France sought to accelerate COVID-19 inoculations on Monday after an initial roll-out slowed by bureaucracy and government wariness in one of the most vaccine-sceptical countries in the world.
It began vaccinating medical staff over the age of 50 after delivering just 516 COVID shots developed by Pfizer and Germany’s BioNTech during the first week of a campaign that focused on the elderly in nursing homes.
The slow start compared to European neighbours such as Britain and Germany has irritated President Emmanuel Macron who told people close to him “things must change fast and hard”, the weekly Journal du Dimanche reported on Sunday.
“It’s going too slowly,” epidemiologist and government adviser Arnaud Fontanet told France Info radio.
“But the real deadline is to reach 5-10 million (vaccinations) by the end of March, because that’s the point at which you have a real impact on the spread of the virus.”
The coronavirus has killed more than 65,000 people in France, the seventh highest national toll globally. Even so, a survey over the weekend showed six in every 10 French citizens intend to refuse vaccination.
Fontanet said it would be “useful” to simplify the bureaucracy involved in the vaccination roll-out. He stopped short of saying whether a mandatory consultation with a doctor several days before getting a COVID jab was time wasted.
A slow vaccination campaign risks jeopardising France’s recovery from an unprecedented economic slump in a time of peace.
France’s National Academy of Medicine last week said the government was taking “excessive precautions”. Government officials have said vaccinating in care homes was complex logistically.
A spokesman for nursing home operator Korian said that it had been told to be ready for vaccinations to be conducted in the greater Paris area on Monday but that the doses had not yet been delivered.
Britain, which has put more than a million COVID-19 vaccines into arms already, began vaccinating its population with the shot developed by Oxford University and AstraZeneca, boasting a scientific triumph.
Dominique Le Guludec, head of France’s medical regulator, said there was still insufficient data to approve the AstraZeneca vaccine.
“We prefer to wait another 15 days if necessary to have all the data we need on safety and efficacy,” Le Guludec told BFM TV.
The EU’s medical watchdog is expected to decide on approval of a third vaccine, developed by Moderna, later this week.
France on Monday sent 12 million pupils back to school after the Christmas holidays as planned.
Restaurants, bars, museums and cinemas remain shut. It was unlikely restaurants would re-open as initially planned on Jan. 20, Alain Griset, a government minister said on Sunday.
Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor